Yayın:
Continued efficacy and safety through 4 years of tenofovir disoproxil fumarate (tdf) treatment in hbeag-negative patients with chronic hepatitis b (study 102): Preliminary analysis

Basit Görünüm
dc.contributor.authorMarcellin, Patric
dc.contributor.authorButi, Maria
dc.contributor.authorKrastev, Zahary
dc.contributor.authorDi Bisceglie, Adrian M.
dc.contributor.authorOdin, Joseph A.
dc.contributor.authorDusheiko, Geoffrey
dc.contributor.authorHeathcote, E. Jenny
dc.contributor.authorE. Jenny, Katyna
dc.contributor.authorCoombs, Derek
dc.contributor.authorMondou, Elsa
dc.contributor.authorAnderson, Jane
dc.contributor.buuauthorGürel, Selim
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentİç Hastalıkları Ana Bilim Dalı
dc.date.accessioned2022-09-15T07:21:36Z
dc.date.available2022-09-15T07:21:36Z
dc.date.issued2010-10
dc.descriptionBu çalışma, 29 Ekim-02 Kasım 2010 tarihleri arasında Boston[Amerika Birleşik Devletleri]’da düzenlenen 61. Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases’da bildiri olarak sunulmuştur.
dc.description.sponsorshipAmer Assoc Study Liver Dis
dc.identifier.citationMarcellin, P. vd. (2010). "Continued efficacy and safety through 4 years of tenofovir disoproxil fumarate (tdf) treatment in hbeag-negative patients with chronic hepatitis b (study 102): Preliminary analysis". Hepatology, 52(4), Supplement, 555A-556A.
dc.identifier.endpage556A
dc.identifier.issn0270-9139
dc.identifier.issue4, Supplement
dc.identifier.startpage555A
dc.identifier.urihttp://hdl.handle.net/11452/28736
dc.identifier.volume52
dc.identifier.wos000288775600481
dc.indexed.wosSCIE
dc.indexed.wosCPCIS
dc.language.isoen
dc.publisherWiley
dc.relation.collaborationYurt dışı
dc.relation.collaborationSanayi
dc.relation.journalHepatology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectGastroenterology & hepatology
dc.subject.wosGastroenterology & hepatology
dc.titleContinued efficacy and safety through 4 years of tenofovir disoproxil fumarate (tdf) treatment in hbeag-negative patients with chronic hepatitis b (study 102): Preliminary analysis
dc.typeOther
dc.type.subtypeMeeting Abstract
dc.wos.quartileQ1
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/İç Hastalıkları Ana Bilim Dalı
local.indexed.atWOS

Dosyalar

Lisanslı seri

Şimdi gösteriliyor 1 - 1 / 1
Placeholder
Ad:
license.txt
Boyut:
1.71 KB
Format:
Item-specific license agreed upon to submission
Açıklama
İndir

Koleksiyonlar

İndeksli Yayınlar / Indexed Publications